-
The condom breaks or the pill pack stays at home on a weekend vacation. What will happen next? In Canada, women in all provinces will be able to go directly to the drug store for behind-the-counter access to emergency contraception (EC), based on the direction of regulatory wheels now set in motion.
-
What is your approach when it comes to discussing intrauterine contraception? It may be time to update your practice, based on information presented at the recent clinical meeting of the Washington, DC-based American College of Obstetricians and Gynecologists (ACOG) and newly published research.
-
Add the latest research finding to your counseling on progestin-only injectable and implant contraception: Results from a large U.S. study provide further evidence that these types of birth control do not raise a womans risk of breast cancer.
-
According to AGI's study, contraceptive coverage improved dramatically between 1993 and 2002 among health plans purchased by employers for their employees.In 2001 and 2002, AGI researchers surveyed insurance companies across the nation, asking whether prescription contraceptives and other comparable drugs, devices, and services were covered in the "typical" managed care plans they wrote for their employers.
-
A laboratory report indicating susceptibility of MRSA to vancomycin does not guarantee successful therapy with this antibiotic since a significant risk for failure may be present despite MICs within the range considered susceptible.
-
Molecular techniques provide a more rapid and accurate method of Nocardia species identification than do classical microbiologic methods. A surprise: of 94 isolates, the most commonly identified species was Nocardia cyriacigeorgica and none were Nocardia asteroides.
-
CPR values as a continuous variable have independent predictive value for subsequent coronary events in apparently healthy women.
-
Data showed a strong trend toward benefit with ICD therapy in patients with nonischemic cardiomyopathy.
-
The pre-discharge initiation of beta blocker therapy for decompensated heart failure patients increased the number of patients on beta blockers at 60 days without an increase in length of stay or adverse effects.
-